Cargando...
Degludec: the new ultra-long insulin analogue
The development of extended-action insulin analogues was motivated by the unfavorable pharmacokinetic (PK) profile of the conventional long-acting insulin formulations, generally associated with marked inter and intra patient variability and site- and dose-dependent effect variation. The new ultra-l...
Gardado en:
| Publicado en: | Diabetol Metab Syndr |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486707/ https://ncbi.nlm.nih.gov/pubmed/26136850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-015-0037-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|